Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
  • Listen Now Playing Listen

This archival content was originally written for and published on KPCC.org. Keep in mind that links and images may no longer work — and references may be outdated.

KPCC Archive

CVS settles lawsuit for $75 million over selling meth ingredient

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today.

Listen 1:04
CVS settles lawsuit for $75 million over selling meth ingredient
CVS settles lawsuit for $75 million over selling meth ingredient

CVS Pharmacy has agreed to pay a multi-million dollar penalty after federal investigators found it had sold large amounts of cold medicine to drug traffickers in Southern California. Cold medicine has the chemicals that drug traffickers use to make methamphetamine.

The U.S. Attorney says between September of 2007 and November of 2008, CVS let people buy a lot more cold medicine with pseudoephedrine than federal law allows. Pseudoephedrine is a key ingredient in methamphetamine.

Federal investigators say CVS had a system in place that didn’t catch people buying more than the law allows. Investigators caught thousands of violations in L.A. and Orange counties and in the Las Vegas area.

In some cases, people bought so much pseudoephedrine that they wiped out store shelves. Investigators say those sales led directly to an increase in meth production in California. They say CVS didn’t change its system until it found out it was being investigated.

Now, the retail drug store chain has agreed to settle the case for $75 million, plus nearly $3 million in profits from those sales. Officials say the settlement is the largest civil penalty under the federal Controlled Substances Act.

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive from readers like you will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today